Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Human Pathology
|
May 21, 2021
MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories
Claire Bocciarelli, Charline Caumont, Laura Samaison, et al.
Genes, Chromosomes & Cancer
|
December 21, 2016
Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome
Damien Luque Paz, Aurélie Chauveau, Françoise Boyer, et al.
Journal of Clinical Pathology
|
April 11, 2020
Evaluation of <i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> mutational status and microsatellite instability in early colorectal carcinomas invading the <i>submucosa</i> (pT1): towards an in-house molecular prognostication for pathologists?
Amélie Bourhis, Caterina De Luca, Mélanie Cariou, et al.
Pathology
|
November 28, 2018
High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses
Fanny Barel, Anaïs Auffret, Mélanie Cariou, et al.
Scientific Reports
|
June 8, 2019
Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer
Fanny Barel, Mélanie Cariou, Philippe Saliou, et al.
Frontiers in Nuclear Medicine
|
October 2, 2024
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
Vincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Human Pathology
|
May 21, 2021
MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories
Claire Bocciarelli, Charline Caumont, Laura Samaison, et al.
Genes, Chromosomes & Cancer
|
December 21, 2016
Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome
Damien Luque Paz, Aurélie Chauveau, Françoise Boyer, et al.
Journal of Clinical Pathology
|
April 11, 2020
Evaluation of <i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> mutational status and microsatellite instability in early colorectal carcinomas invading the <i>submucosa</i> (pT1): towards an in-house molecular prognostication for pathologists?
Amélie Bourhis, Caterina De Luca, Mélanie Cariou, et al.
Pathology
|
November 28, 2018
High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses
Fanny Barel, Anaïs Auffret, Mélanie Cariou, et al.
Scientific Reports
|
June 8, 2019
Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer
Fanny Barel, Mélanie Cariou, Philippe Saliou, et al.
Frontiers in Nuclear Medicine
|
October 2, 2024
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
Vincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.
Page
of 2